LON:CIR - Circassia Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 37.80
▼ -0.2 (-0.53%)

This chart shows the closing price for CIR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Circassia Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CIR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CIR

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Circassia Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 37.80.

This chart shows the closing price for CIR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Circassia Group. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/26/2021Peel HuntReiterated RatingUnder Review
5/26/2021Peel HuntReiterated RatingUnder review
6/16/2020Peel HuntReiterated RatingUnder Review
6/16/2020FinnCapReiterated RatingCorporate
6/2/2020Peel HuntReiterated RatingUnder Review
5/28/2020FinnCapReiterated RatingCorporate
5/1/2020Peel HuntReiterated RatingUnder Review
4/24/2020Peel HuntReiterated RatingUnder Review
4/17/2020FinnCapReiterated RatingCorporate
4/7/2020Peel HuntReiterated RatingBuy
3/5/2020Peel HuntReiterated RatingBuy
2/13/2020Peel HuntReiterated RatingBuy
2/5/2020Peel HuntReiterated RatingBuy
1/27/2020Peel HuntReiterated RatingBuy
1/9/2020Peel HuntReiterated RatingBuy
1/9/2020FinnCapReiterated RatingCorporate
12/19/2019Peel HuntReiterated RatingBuy
12/5/2019FinnCapReiterated RatingCorporate
12/5/2019Peel HuntReiterated RatingBuy
11/4/2019Peel HuntReiterated RatingBuy
10/21/2019Peel HuntReiterated RatingBuy
10/15/2019Peel HuntReiterated RatingBuyGBX 70
10/15/2019Peel HuntLower Price TargetBuyGBX 90 ➝ GBX 70
10/7/2019Peel HuntReiterated RatingBuy
9/26/2019FinnCapInitiated CoverageCorporateGBX 80
9/26/2019Peel HuntReiterated RatingBuy
9/2/2019Peel HuntReiterated RatingBuy
8/12/2019Peel HuntReiterated RatingBuy
8/1/2019Peel HuntReiterated RatingBuy
7/3/2019Peel HuntReiterated RatingBuy
6/4/2019Peel HuntReiterated RatingBuy
5/8/2019Peel HuntReiterated RatingBuy
5/1/2019Numis SecuritiesReiterated RatingBuyGBX 110
5/1/2019Peel HuntReiterated RatingBuyGBX 90
4/23/2019Peel HuntReiterated RatingBuy
4/1/2019Numis SecuritiesReiterated RatingBuyGBX 110
4/1/2019Peel HuntReiterated RatingBuy
3/12/2019Peel HuntReiterated RatingBuyGBX 90
2/1/2019Peel HuntReiterated RatingUnder Review
1/24/2019Peel HuntReiterated RatingUnder Review
1/24/2019Royal Bank of CanadaLower Price TargetSector PerformerGBX 81 ➝ GBX 65
1/4/2019Peel HuntReiterated RatingUnder Review
12/18/2018Peel HuntReiterated RatingBuy
12/12/2018Peel HuntReiterated RatingBuy
12/6/2018Peel HuntReiterated RatingBuy
11/1/2018Peel HuntReiterated RatingBuy
10/17/2018Royal Bank of CanadaLower Price TargetSector PerformerGBX 86 ➝ GBX 81
10/3/2018Peel HuntReiterated RatingBuy
9/27/2018Numis SecuritiesReiterated RatingBuyGBX 140
9/27/2018Peel HuntUpgradeBuy
9/4/2018Peel HuntReiterated RatingHold
8/13/2018Peel HuntReiterated RatingHold
8/1/2018Peel HuntReiterated RatingHold
7/3/2018Peel HuntReiterated RatingHold
5/31/2018Peel HuntReiterated RatingHold
5/22/2018Peel HuntReiterated RatingHold
5/16/2018Peel HuntLower Price TargetHoldGBX 130 ➝ GBX 120
5/15/2018JPMorgan Chase & Co.Lower Price TargetNeutralGBX 125 ➝ GBX 100
4/24/2018JPMorgan Chase & Co.Reiterated RatingNeutral
4/24/2018Numis SecuritiesLower Price TargetBuyGBX 180 ➝ GBX 140
4/24/2018Peel HuntReiterated RatingHoldGBX 130
4/4/2018Peel HuntReiterated RatingHold
3/1/2018Peel HuntReiterated RatingHoldGBX 130
2/1/2018Peel HuntReiterated RatingHoldGBX 130
1/4/2018Peel HuntReiterated RatingHoldGBX 130
12/4/2017Numis SecuritiesReiterated RatingBuyGBX 180
10/31/2017Peel HuntReiterated RatingHoldGBX 130
9/28/2017JPMorgan Chase & Co.Lower Price TargetNeutralGBX 120 ➝ GBX 110
9/27/2017Numis SecuritiesReiterated RatingBuyGBX 180
9/27/2017Peel HuntReiterated RatingHoldGBX 130
9/8/2017JPMorgan Chase & Co.Reiterated RatingNeutral
9/7/2017Numis SecuritiesReiterated RatingBuyGBX 180
5/26/2017Numis SecuritiesReiterated RatingBuyGBX 174
5/23/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 120
4/26/2017Peel HuntDowngradeHoldGBX 150 ➝ GBX 130
4/25/2017Stifel NicolausReiterated RatingBuyGBX 150
4/25/2017Peel HuntReiterated RatingAddGBX 150
4/25/2017Numis SecuritiesReiterated RatingBuyGBX 174
4/19/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 105
4/4/2017Numis SecuritiesReiterated RatingBuyGBX 174
4/4/2017Stifel NicolausReiterated RatingBuyGBX 150
3/28/2017JPMorgan Chase & Co.Reiterated RatingNeutralGBX 105
3/20/2017Stifel NicolausUpgradeBuyGBX 99 ➝ GBX 150
3/20/2017JPMorgan Chase & Co.Reiterated RatingNeutral
2/24/2017Peel HuntLower Price TargetAddGBX 160 ➝ GBX 150
1/17/2017JPMorgan Chase & Co.Reiterated RatingNeutral
1/4/2017JPMorgan Chase & Co.DowngradeNeutralGBX 140 ➝ GBX 105
9/28/2016JPMorgan Chase & Co.Lower Price TargetOverweightGBX 170 ➝ GBX 140
9/27/2016Peel HuntReiterated RatingAddGBX 160
9/27/2016Numis SecuritiesReiterated RatingBuyGBX 150
(Data available from 9/23/2016 forward)

News Sentiment Rating

0.26 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/23/2021

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Circassia Group logo
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products through commercial team in the United States, China, the United Kingdom, and Germany, as well as through network of distribution partners internationally. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Read More

Today's Range

Now: GBX 37.80
Low: 37.50
High: 38.49

50 Day Range

MA: GBX 36.63
Low: 29.05
High: 41.25

52 Week Range

Now: GBX 37.80
Low: 19.86
High: 42.24

Volume

1,148,296 shs

Average Volume

825,445 shs

Market Capitalization

£158.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Circassia Group?

The following Wall Street analysts have issued stock ratings on Circassia Group in the last twelve months: Peel Hunt, and Peel Hunt LLP.
View the latest analyst ratings for CIR.

What is the current price target for Circassia Group?

0 Wall Street analysts have set twelve-month price targets for Circassia Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Circassia Group in the next year.
View the latest price targets for CIR.

What is the current consensus analyst rating for Circassia Group?

Circassia Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CIR.

How do I contact Circassia Group's investor relations team?

Circassia Group's physical mailing address is 30 Corporate Dr., Suite 200, Burlington, Massachusetts 01803-4238. The company's listed phone number is 44 1865 405 560. The official website for Circassia Group is www.circassia.co.uk.